Literature DB >> 3170147

New biologies and therapies for breast cancer.

B M Cantwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3170147     DOI： 10.1007/bf02949304

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  4 in total

1.  Suppression of postmenopausal ovarian steroidogenesis with the luteinizing hormone-releasing hormone agonist goserelin.

Authors:  M Dowsett; B Cantwell; A Lal; S L Jeffcoate; A L Harris
Journal:  J Clin Endocrinol Metab       Date:  1988-04       Impact factor: 5.958

2.  Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine-needle aspirates.

Authors:  R C Coombes; T J Powles; U Berger; P Wilson; R A McClelland; J C Gazet; P A Trott; H T Ford
Journal:  Lancet       Date:  1987-09-26       Impact factor: 79.321

Review 3.  Advanced breast cancer: high-dose chemotherapy and bone marrow autotransplants.

Authors:  K Antman; R P Gale
Journal:  Ann Intern Med       Date:  1988-04       Impact factor: 25.391

4.  Phase II study of the antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717) in advanced breast cancer.

Authors:  B M Cantwell; V Macaulay; A L Harris; S B Kaye; I E Smith; R A Milsted; A H Calvert
Journal:  Eur J Cancer Clin Oncol       Date:  1988-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.